Among those who have already survived one cardiac crisis, nearly half are lying awake at night — and that sleeplessness, a Norwegian study now suggests, is not merely a symptom of worry but a force quietly shaping their odds of survival. Presented at a European cardiology conference, the research followed more than a thousand heart patients over four years and found that insomnia ranked third among modifiable risk factors for recurrent cardiac events, behind only smoking and physical inactivity. The finding places something as intimate and invisible as a restless night alongside the most estab
Insomnia ranks third risk factor for repeat heart events in cardiac patients
Cobertura Relacionada
Hundreds of thousands of UK students received GCSE results showing overall grade improvements in 2025, with the gender g…
The Straits Times · Aug 20 Ebola spreads beyond Congo epicentre, overwhelming treatment capacityEbola cases in DRC are accelerating outside the initial Ituri epicenter, with North Kivu and Haut-Uélé provinces experie…
Science Daily · Aug 20 1,000+ genetic switches explain why women face higher autoimmune disease riskResearchers identified over 1,000 genetic switches that function differently in male and female immune cells, explaining…
News-Medical · Aug 20 Brain's Local Wiring May Buffer Cognitive Decline in Older AdultsUSC researchers found that white matter integrity helps protect cognitive function in older adults by compensating for g…
Viés e Enquadramento
UPI presents a straightforward medical study report on insomnia as a cardiac risk factor with minimal apparent bias, using neutral language and direct attribution.
Objective medical reporting with emphasis on research findings and expert attribution. The article frames insomnia as a significant but quantifiable risk factor, presenting data-driven conclusions without sensationalism.
Impacto Geopolítico
This is a medical research article about insomnia as a cardiac risk factor, not a geopolitical issue.
Lente Econômica
Study identifies insomnia as third-leading risk factor for repeat cardiac events (16%), creating economic implications for healthcare costs, pharmaceutical demand, and workplace productivity losses.
Cardiac patients face increased healthcare costs from insomnia screening and treatment. Consumers may experience higher insurance premiums as insurers account for sleep disorder management. Increased demand for sleep medications, cognitive behavioral therapy, and sleep monitoring devices will raise out-of-pocket costs for affected populations.
Healthcare systems may implement mandatory sleep disorder screening protocols for cardiac patients, increasing reimbursement claims. Insurance policies may expand coverage for sleep treatments. Occupational health regulations could mandate workplace sleep wellness programs. FDA may accelerate approval of sleep disorder therapeutics. Public health campaigns may promote sleep hygiene as cardiovascular prevention.